JENBURKT PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JENBURKT PHARMACEUTICALS have increased by 10.30% YoY .
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 5.56 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
JENBURKT PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524731]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹137 Cr | ₹124 Cr | ₹109 Cr | ₹119 Cr | ₹123 Cr |
| Expenses | ₹106 Cr | ₹97 Cr | ₹89 Cr | ₹99 Cr | ₹98 Cr |
| Operating Profit (Excl OI) | ₹30 Cr | ₹27 Cr | ₹20 Cr | ₹20 Cr | ₹25 Cr |
| Other Income | ₹5.12 Cr | ₹4.95 Cr | ₹4.31 Cr | ₹4.22 Cr | ₹3.45 Cr |
| Interest | ₹0.37 Cr | ₹0.43 Cr | ₹0.47 Cr | ₹0.53 Cr | ₹0.39 Cr |
| Depreciation | ₹2.26 Cr | ₹1.90 Cr | ₹2.04 Cr | ₹2.30 Cr | ₹1.35 Cr |
| Profit Before Tax | ₹33 Cr | ₹30 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr |
| Profit After Tax | ₹25 Cr | ₹22 Cr | ₹17 Cr | ₹15 Cr | ₹20 Cr |
| Earnings Per Share (Rs) | ₹58.86 | ₹55.76 | ₹48.58 | ₹35.96 | ₹32.40 |
| PAT Margin (%) | 18.30 | 17.99 | 17.98 | 15.10 | 12.51 |
| ROE(%) | 19.43 | 20.53 | 20.66 | 18.49 | 18.89 |
| ROCE(%) | 26.28 | 26.80 | 26.89 | 23.83 | 25.73 |
| Total Debt/Equity(x) | 0.00 | 0.02 | 0.05 | 0.04 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 553.8 Cr |
| Revenue (TTM) | : | ₹ 148.3 Cr |
| Net Profit(TTM) | : | ₹ 30.3 Cr |
| EPS (TTM) | : | ₹ 68.9 |
| P/E (TTM) | : | 18.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JENBURKT PHARMACEUTICALS | 0.4% | -4.1% | 61.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -3.7% | -2.5% | 31.9% |
| CIPLA | -3.2% | 0% | 8.2% |
| DR REDDYS LABORATORIES | -2.4% | 7.3% | 15.3% |
| ZYDUS LIFESCIENCES | 2% | 2.3% | 37.9% |
| DIVIS LABORATORIES | 2.3% | 2.1% | 46.9% |
| MANKIND PHARMA | -7.1% | 1.2% | 20.5% |
| TORRENT PHARMACEUTICALS | -2.1% | -2.8% | 37.8% |
| LUPIN | -4.3% | 3.8% | 53.3% |
JENBURKT PHARMACEUTICALS Revenues
[BOM: 524731]
| Y-o-Y | 10.30 % |
| 5 Yr CAGR | 2.76 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹137 Cr | 10.30 | |
| Mar2023 | ₹124 Cr | 13.44 | |
| Mar2022 | ₹109 Cr | -8.07 | |
| Mar2021 | ₹119 Cr | -3.06 | |
| Mar2020 | ₹123 Cr | - | |
JENBURKT PHARMACEUTICALS Operating Profit
[BOM: 524731]
| Y-o-Y | 11.42 % |
| 5 Yr CAGR | 5.06 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹30 Cr | 11.42 | |
| Mar2023 | ₹27 Cr | 37.36 | |
| Mar2022 | ₹20 Cr | 0.50 | |
| Mar2021 | ₹20 Cr | -20.79 | |
| Mar2020 | ₹25 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.05 % |
| 5 Yr CAGR | 2.25 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 22.21% | 1.05 | |
| Mar2023 | 21.98% | 21.10 | |
| Mar2022 | 18.15% | 9.27 | |
| Mar2021 | 16.61% | -18.26 | |
| Mar2020 | 20.32% | - | |
JENBURKT PHARMACEUTICALS Profit After Tax
[BOM: 524731]
| Y-o-Y | 10.36 % |
| 5 Yr CAGR | 5.59 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹25 Cr | 10.36 | |
| Mar2023 | ₹22 Cr | 35.12 | |
| Mar2022 | ₹17 Cr | 10.98 | |
| Mar2021 | ₹15 Cr | -24.89 | |
| Mar2020 | ₹20 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.72 % |
| 5 Yr CAGR | 9.98 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 18.3 % | 1.72 | |
| Mar2023 | 17.99 % | 0.06 | |
| Mar2022 | 17.98 % | 19.07 | |
| Mar2021 | 15.1 % | 20.70 | |
| Mar2020 | 12.51 % | - | |
JENBURKT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524731]
| Y-o-Y | 5.56 % |
| 5 Yr CAGR | 16.10 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹59 | 5.56 | |
| Mar2023 | ₹56 | 14.78 | |
| Mar2022 | ₹49 | 35.09 | |
| Mar2021 | ₹36 | 10.99 | |
| Mar2020 | ₹32 | - | |
JENBURKT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524731]
| Y-o-Y | -1.94 % |
| 5 Yr CAGR | 0.53 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 26.28% | -1.94 | |
| Mar2023 | 26.8% | -0.33 | |
| Mar2022 | 26.89% | 12.84 | |
| Mar2021 | 23.83% | -7.38 | |
| Mar2020 | 25.73% | - | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,258.6 |
| Current MarketCap | : | ₹ 553.8 Cr |
| Updated EOD on | : | Jan 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 0.4% |
-4.1% |
61.1% |
| SENSEX | -2.2% |
-5.9% |
7.2% |
JENBURKT PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about JENBURKT PHARMACEUTICALS Financials
How the annual revenues of JENBURKT PHARMACEUTICALS have changed ?
The Revenues of JENBURKT PHARMACEUTICALS have increased by 10.30% YoY .
How the Earnings per Share (EPS) of JENBURKT PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JENBURKT PHARMACEUTICALS has increased by 5.56 % YoY .
Check out Intrinsic Value of Peers of JENBURKT PHARMACEUTICALS
Compare Stock Analytics of Peers of JENBURKT PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
